APP and cerebral amyloid angiopathy: Notably, deletion of CD36 reduces cerebral amyloid angiopathy in amyloid precursor protein (APP)-overexpressing mice, likely by enhancing brain-to-blood clearance via endothelial CD36 rather than microglial mechanisms [66].